1. Home
  2. STRO vs CMU Comparison

STRO vs CMU Comparison

Compare STRO & CMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • CMU
  • Stock Information
  • Founded
  • STRO 2003
  • CMU 1987
  • Country
  • STRO United States
  • CMU United States
  • Employees
  • STRO N/A
  • CMU N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • CMU Investment Managers
  • Sector
  • STRO Health Care
  • CMU Finance
  • Exchange
  • STRO Nasdaq
  • CMU Nasdaq
  • Market Cap
  • STRO 77.7M
  • CMU 85.1M
  • IPO Year
  • STRO 2018
  • CMU N/A
  • Fundamental
  • Price
  • STRO $0.80
  • CMU $3.36
  • Analyst Decision
  • STRO Hold
  • CMU
  • Analyst Count
  • STRO 7
  • CMU 0
  • Target Price
  • STRO $3.97
  • CMU N/A
  • AVG Volume (30 Days)
  • STRO 833.9K
  • CMU 82.4K
  • Earning Date
  • STRO 08-12-2025
  • CMU 01-01-0001
  • Dividend Yield
  • STRO N/A
  • CMU 4.08%
  • EPS Growth
  • STRO N/A
  • CMU N/A
  • EPS
  • STRO N/A
  • CMU 0.07
  • Revenue
  • STRO $66,434,000.00
  • CMU N/A
  • Revenue This Year
  • STRO N/A
  • CMU N/A
  • Revenue Next Year
  • STRO N/A
  • CMU N/A
  • P/E Ratio
  • STRO N/A
  • CMU $47.57
  • Revenue Growth
  • STRO N/A
  • CMU N/A
  • 52 Week Low
  • STRO $0.52
  • CMU $2.78
  • 52 Week High
  • STRO $5.17
  • CMU $3.38
  • Technical
  • Relative Strength Index (RSI)
  • STRO 46.11
  • CMU 49.35
  • Support Level
  • STRO $0.76
  • CMU $3.33
  • Resistance Level
  • STRO $0.94
  • CMU $3.39
  • Average True Range (ATR)
  • STRO 0.07
  • CMU 0.03
  • MACD
  • STRO -0.01
  • CMU 0.00
  • Stochastic Oscillator
  • STRO 29.11
  • CMU 50.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.

Share on Social Networks: